4.0 Article

Genome-wide gene expression analysis in mouse embryonic stem cells

Journal

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
Volume 55, Issue 10-12, Pages 995-1006

Publisher

UNIV BASQUE COUNTRY UPV-EHU PRESS
DOI: 10.1387/ijdb.103123js

Keywords

mouse stem cell line; gene expression profiling; early differentiation

Funding

  1. Consejeria de Salud de la Junta de Andalucia, Sevilla [P08-TIC-4299]
  2. DGICT Ministerio de Educacion y Ciencia, Madrid, Spain [TIN2009-13177]

Ask authors/readers for more resources

Embryonic stem cell studies have generated great interest, due to their ability to form a wide variety of matured cells. However, there remains a poor understanding of mechanisms regulating the cell state of embryonic stem cells (ESCs) and of the genes they express during early differentiation. Gene expression analysis may be a valuable tool to elucidate either the molecular pathways involved in self-renewal and pluripotency, or early differentiation and to identify potential molecular therapy targets. The aim of this study was to characterize at the molecular level the undifferentiated mouse ESC state and the early development towards embryoid bodies. To attempt this issue, we performed CodeLink Mouse Uniset I 20K bioarrays in a well-characterized mouse ESC line, MES3, 3- and 7 day-old embryoid bodies and we compared our findings with those in adult tissue cells. Gene expression results were subsequently validated in a commercial stem cell line, CGR8 (ATCC). SignificanceAnalysis of Microarrays (SAM) was used to identify statistically significant changes in microarray data. We identified 3664 genes expressed at significantly greater levels in MES3 stem cells than in adult tissue cells, which included 611 with 3-fold higher gene expression levels versus the adult cells. We also investigated the gene expression profile during early embryoid body formation, identifying 2040 and 2243 genes that were up-regulated in 3- and 7-day-old embryoid bodies, respectively. Our gene expression results in MES3 cells were partially confirmed in CGR8 cells, showing numerous genes that are expressed in both mouse stem cells. In conclusion, our results suggest that commonly expressed genes may be strong candidates for involvement in the maintenance of a pluripotent and undifferentiated phenotype and in early development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

Angelica Macauda, Matteo Giaccherini, Juan Sainz, Federica Gemignani, Nicola Sgherza, Jose Manuel Sanchez-Maldonado, Joanna Gora-Tybor, Joaquin Martinez-Lopez, Gonzalo Carreno-Tarragona, Andres Jerez, Raffaele Spadano, Aleksandra Golos, Manuel Jurado, Francisca Hernandez-Mohedo, Grzegorz Mazur, Francesca Tavano, Aleksandra Butrym, Judit Varkonyi, Federico Canzian, Daniele Campa

Summary: There may be a common genetic background between MPN and MM, but further investigation is needed to fully understand the mechanisms behind it.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

Ombretta Melaiu, Angelica Macauda, Juan Sainz, Diego Calvetti, Maria Sole Facioni, Giuseppe Maccari, Rob ter Horst, Mihai G. Netea, Yang Li, Norbert Grzasko, Victor Moreno, Artur Jurczyszyn, Andres Jerez, Marzena Watek, Judit Varkonyi, Ramon Garcia-Sanz, Marcin Kruszewski, Marek Dudzinski, Katalin Kadar, Svend Erik Hove Jacobsen, Grzegorz Mazur, Vibeke Andersen, Malwina Rybicka, Daria Zawirska, Malgorzata Razny, Jan Maciej Zaucha, Olga Ostrovsky, Elzbieta Iskierka-Jazdzewska, Rui Manuel Reis, Anna Stepien, Katia Beider, Arnon Nagler, Agnieszka Druzd-Sitek, Herlander Marques, Joaquin Martinez-Lopez, Fabienne Lesueur, Herve Avet-Loiseau, Annette Juul Vangsted, Malgorzata Krawczyk-Kulis, Aleksandra Butrym, Krzysztof Jamroziak, Charles Dumontet, Ulla Vogel, Marcin Rymko, Matteo Pelosini, Edyta Subocz, Gergely Szombath, Maria Eugenia Sarasquete, Roberto Silvestri, Federica Morani, Stefano Landi, Daniele Campa, Federico Canzian, Federica Gemignani

Summary: This study evaluated the association between germline genetic variants in the 3' untranslated region of candidate genes and multiple myeloma (MM), finding that IL10-rs3024496 was associated with increased MM risk and poorer survival. Functional analysis showed that the variant allele had lower expression of the reporter gene, consistent with in vivo mRNA expression data. These findings suggest a potential clinical implication for better characterizing MM patients in terms of prognosis.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Microbiology

Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium

Jose Manuel Sanchez-Maldonado, Ana Moniz-Diez, Rob ter Horst, Daniele Campa, Antonio Jose Cabrera-Serrano, Manuel Martinez-Bueno, Maria del Pilar Garrido-Collado, Francisca Hernandez-Mohedo, Laura Fernandez-Puerta, Miguel Angel Lopez-Nevot, Cristina Cunha, Pedro Antonio Gonzalez-Sierra, Jan Springer, Michaela Lackner, Laura Alcazar-Fuoli, Luana Fianchi, Jose Maria Aguado, Livio Pagano, Elisa Lopez-Fernandez, Esther Clavero, Leonardo Potenza, Mario Luppi, Lucia Moratalla, Carlos Solano, Antonio Sampedro, Manuel Cuenca-Estrella, Cornelia Lass-Florl, Federico Canzian, Juergen Loeffler, Yang Li, Hermann Einsele, Mihai G. Netea, Lourdes Vazquez, Agostinho Carvalho, Manuel Jurado, Juan Sainz

Summary: The study assessed the influence of 36 single nucleotide polymorphisms (SNPs) within the TNFSF4 and MAPKAPK2 loci on the risk of developing invasive aspergillosis (IA). The results showed that carriers of specific genotypes and alleles within these loci were associated with increased or decreased risk of IA, indicating roles of TNFSF4 and MAPKAPK2 genes in determining IA risk.

JOURNAL OF FUNGI (2021)

Article Oncology

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

Angelica Macauda, Chiara Piredda, Alyssa Clay-Gilmour, Juan Sainz, Gabriele Buda, Miroslaw Markiewicz, Torben Barington, Elad Ziv, Michelle A. T. Hildebrandt, Alem A. Belachew, Judit Varkonyi, Witold Prejzner, Agnieszka Druzd-Sitek, John Spinelli, Niels Frost Andersen, Jonathan N. Hofmann, Marek Dudzinski, Joaquin Martinez-Lopez, Elzbieta Iskierka-Jazdzewska, Roger L. Milne, Grzegorz Mazur, Graham G. Giles, Lene Hyldahl Ebbesen, Marcin Rymko, Krzysztof Jamroziak, Edyta Subocz, Rui Manuel Reis, Ramon Garcia-Sanz, Anna Suska, Eva Kannik Haastrup, Daria Zawirska, Norbert Grzasko, Annette Juul Vangsted, Charles Dumontet, Marcin Kruszewski, Magdalena Dutka, Nicola J. Camp, Rosalie G. Waller, Waldemar Tomczak, Matteo Pelosini, Malgorzata Razny, Herlander Marques, Niels Abildgaard, Marzena Watek, Artur Jurczyszyn, Elizabeth E. Brown, Sonja Berndt, Aleksandra Butrym, Celine M. Vachon, Aaron D. Norman, Susan L. Slager, Federica Gemignani, Federico Canzian, Daniele Campa

Summary: Gene expression profiling and eQTL analysis revealed a potential association between specific SNPs in the TBRG4 gene and overall survival of multiple myeloma patients. These findings may aid in predicting survival outcomes and guiding personalized treatment strategies for MM.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts

Juan Sainz, Francisco Jose Garcia-Verdejo, Manuel Martinez-Bueno, Abhishek Kumar, Jose Manuel Sanchez-Maldonado, Anna Diez-Villanueva, Ludmila Vodickova, Veronika Vymetalkova, Vicente Martin Sanchez, Miguel Inacio Da Silva Filho, Belem Sampaio-Marques, Stefanie Brezina, Katja Butterbach, Rob ter Horst, Michael Hoffmeister, Paula Ludovico, Manuel Jurado, Yang Li, Pedro Sanchez-Rovira, Mihai G. Netea, Andrea Gsur, Pavel Vodicka, Victor Moreno, Kari Hemminki, Hermann Brenner, Jenny Chang-Claude, Asta Foersti

Summary: Through a meta-analysis of genome-wide association study data, this study identified DAPK2 and ATG5 loci as being associated with colorectal cancer risk in European cohorts. Specifically, genetic variants within these loci were found to impact host immune responses and levels of inflammatory proteins, potentially contributing to cancer development. Additionally, no direct effect on autophagy flux was observed, indicating a complex relationship between genetic variants, immune responses, and cancer risk.

CANCERS (2021)

Article Oncology

Genetically determined telomere length and multiple myeloma risk and outcome

Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, Marcin Rymko, Karolina Gruenpeter, Charles Dumontet, Malgorzata Razny, Victor Moreno, Gabriele Buda, Katia Beider, Judit Varkonyi, Herve Avet-Loiseau, Joaquin Martinez-Lopez, Herlander Marques, Marzena Watek, Maria Eugenia Sarasquete, Vibeke Andersen, Lionel Karlin, Anna Suska, Marcin Kruszewski, Niels Abildgaard, Marek Dudzinski, Aleksandra Butrym, Arnold Nagler, Annette Juul Vangsted, Katalin Kadar, Tomczak Waldemar, Krzysztof Jamroziak, Svend Erik Hove Jacobsen, Lene Hyldahl Ebbesen, Michal Taszner, Grzegorz Mazur, Fabienne Lesueur, Matteo Pelosini, Ramon Garcia-Sanz, Artur Jurczyszyn, Delphine Demangel, Rui Manuel Reis, Elzbieta Iskierka-Jazdzewska, Miroslaw Markiewicz, Federica Gemignani, Edyta Subocz, Daria Zawirska, Agnieszka Druzd-Sitek, Anna Stepien, M. Henar Alonso, Juan Sainz, Federico Canzian, Daniele Campa

Summary: Telomere length is genetically determined and has been associated with multiple myeloma (MM) risk and survival. A study involving 2407 MM patients and 1741 controls found that longer genetically determined telomere length (gdTL) increased the risk of MM, while also potentially improving MM survival. This suggests that gdTL could be a useful marker for MM risk assessment and prognosis.

BLOOD CANCER JOURNAL (2021)

Article Oncology

Functional Genetic Variants in ATG10 Are Associated with Acute Myeloid Leukemia

Isabel Castro, Belem Sampaio-Marques, Anabela C. Areias, Hugo Sousa, Angela Fernandes, Jose Manuel Sanchez-Maldonado, Cristina Cunha, Agostinho Carvalho, Juan Sainz, Paula Ludovico

Summary: Acute myeloid leukemia (AML) is a deadly blood cancer, with single nucleotide polymorphisms (SNPs) being considered as potential candidates for disease prevention. SNPs in the autophagy core gene ATG10, especially ATG10(rs3734114), are associated with increased susceptibility to AML. On the other hand, ATG10(rs1864182) SNP is linked to reduced risk of developing AML.

CANCERS (2021)

Article Biochemistry & Molecular Biology

A polygenic risk score for multiple myeloma risk prediction

Federico Canzian, Chiara Piredda, Angelica Macauda, Daria Zawirska, Niels Frost Andersen, Arnon Nagler, Jan Maciej Zaucha, Grzegorz Mazur, Charles Dumontet, Marzena Watek, Krzysztof Jamroziak, Juan Sainz, Judit Varkonyi, Aleksandra Butrym, Katia Beider, Niels Abildgaard, Fabienne Lesueur, Marek Dudzinski, Annette Juul Vangsted, Matteo Pelosini, Edyta Subocz, Mario Petrini, Gabriele Buda, Malgorzata Razny, Federica Gemignani, Herlander Marques, Enrico Orciuolo, Katalin Kadar, Artur Jurczyszyn, Agnieszka Druzd-Sitek, Ulla Vogel, Vibeke Andersen, Rui Manuel Reis, Anna Suska, Herve Avet-Loiseau, Marcin Kruszewski, Waldemar Tomczak, Marcin Rymko, Stephane Minvielle, Daniele Campa

Summary: Multiple myeloma (MM) risk has a strong genetic background, with 23 risk loci identified through genome-wide association studies (GWAS). Combining SNPs into a polygenic risk score (PRS) showed significant associations with MM risk, providing a first step towards using genetics for risk stratification in the general population.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Letter Oncology

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

Paloma Garcia-Martin, Ana Moniz Diez, Jose Manuel Sanchez Maldonado, Antonio Jose Cabrera Serrano, Rob ter Horst, Yolanda Benavente, Stefano Landi, Angelica Macauda, Alyssa Clay-Gilmour, Francisca Hernandez-Mohedo, Yasmeen Niazi, Pedro Gonzalez-Sierra, Blanca Espinet, Juan Jose Rodriguez-Sevilla, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, Anna Puiggros, James Cerhan, Roberto Marasca, Marisa Canadas-Garre, Miguel Angel Lopez-Nevot, Tzu Chen-Liang, Hauke Thomsen, Irene Gamez, Victor Moreno, Rafael Marcos-Gragera, Maria Garcia-Alvarez, Javier Llorca, Andres Jerez, Sonja Berndt, Aleksandra Butrym, Aaron D. Norman, Delphine Casabonne, Mario Luppi, Susan L. Slager, Kari Hemminki, Yang Li, Miguel Alcoceba, Daniele Campa, Federico Canzian, Silvia de Sanjose, Asta Foersti, Mihai G. Netea, Manuel Jurado, Juan Sainz

BLOOD CANCER JOURNAL (2022)

Article Oncology

Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

Jose Manuel Sanchez-Maldonado, Ricardo Collado, Antonio Jose Cabrera-Serrano, Rob Ter Horst, Fernando Galvez-Montosa, Inmaculada Robles-Fernandez, Veronica Arenas-Rodriguez, Blanca Cano-Gutierrez, Olivier Bakker, Maria Inmaculada Bravo-Fernandez, Francisco Jose Garcia-Verdejo, Jose Antonio Lopez Lopez, Jesus Olivares-Ruiz, Miguel Angel Lopez-Nevot, Laura Fernandez-Puerta, Jose Manuel Cozar-Olmo, Yang Li, Mihai G. Netea, Manuel Jurado, Jose Antonio Lorente, Pedro Sanchez-Rovira, Maria Jesus Alvarez-Cubero, Juan Sainz

Summary: This study evaluated the influence of common variants for type 2 diabetes (T2D) on the risk of developing prostate cancer (PCa). Certain single nucleotide polymorphisms (SNPs) were found to be associated with PCa risk, and T2D SNPs were found to potentially influence PCa risk through the modulation of host immune responses.

CANCERS (2022)

Article Oncology

Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, Michelle A. T. Hildebrandt, Marcin Kruszewski, Robert Z. Orlowski, Shaji K. Kumar, Elad Ziv, Enrico Orciuolo, Elizabeth E. Brown, Asta Forsti, Rosalie G. Waller, Mitchell J. Machiela, Stephen J. Chanock, Nicola J. Camp, Marcin Rymko, Malgorzata Rany, Wendy Cozen, Judit Varkonyi, Chiara Piredda, Matteo Pelosini, Alem A. Belachew, Edyta Subocz, Kari Hemminki, Malwina Rybicka-Ramos, Graham G. Giles, Roger L. Milne, Jonathan N. Hofmann, Jan Maciej Zaucha, Annette Juul Vangsted, Hartmut Goldschmidt, S. Vincent Rajkumar, Waldemar Tomczak, Juan Sainz, Aleksandra Butrym, Marzena Watek, Elzbieta Iskierka-Jazdzewska, Gabriele Buda, Dennis P. Robinson, Artur Jurczyszyn, Marek Dudzinski, Joaquin Martinez-Lopez, Jason P. Sinnwell, Susan L. Slager, Krzysztof Jamroziak, Rui Manuel Vieira Reis, Niels Weinhold, Parveen Bhatti, Luis G. Carvajal-Carmona, Daria Zawirska, Aaron D. Norman, Grzegorz Mazur, Sonja I. Berndt, Daniele Campa, Celine M. Vachon, Federico Canzian

Summary: This study explored the potential association between known risk variants and polygenic risk score with overall survival in multiple populations of European ancestry with multiple myeloma. The results showed that some risk SNPs were associated with overall survival, while the combined polygenic risk score did not show significant association.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

Marco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, Angelica Macauda, Juan Sainz, Mitchell J. Machiela, Malwina Rybicka-Ramos, Aaron D. Norman, Agata Tyczynska, Stephen J. Chanock, Torben Barington, Shaji K. Kumar, Parveen Bhatti, Wendy Cozen, Elizabeth E. Brown, Anna Suska, Eva K. Haastrup, Robert Z. Orlowski, Marek Dudzinski, Ramon Garcia-Sanz, Marcin Kruszewski, Joaquin Martinez-Lopez, Katia Beider, Elzbieta Iskierka-Jazdzewska, Matteo Pelosini, Sonja Berndt, Malgorzata Razny, Krzysztof Jamroziak, S. Vincent Rajkumar, Artur Jurczyszyn, Annette Juul Vangsted, Pilar Garrido Collado, Ulla Vogel, Jonathan N. Hofmann, Mario Petrini, Aleksandra Butrym, Susan L. Slager, Elad Ziv, Edyta Subocz, Graham G. Giles, Niels Frost Andersen, Grzegorz Mazur, Marzena Watek, Fabienne Lesueur, Michelle A. T. Hildebrandt, Daria Zawirska, Lene Hyldahl Ebbesen, Herlander Marques, Federica Gemignani, Charles Dumontet, Judit Varkonyi, Gabriele Buda, Arnon Nagler, Agnieszka Druzd-Sitek, Xifeng Wu, Katalin Kadar, Nicola J. Camp, Norbert Grzasko, Rosalie G. Waller, Celine Vachon, Federico Canzian, Daniele Campa

Summary: The aim of this study was to identify novel pleiotropic variants involved in multiple myeloma (MM) risk. Through analysis of 28,684 single nucleotide polymorphisms (SNPs), DNAJB4-rs34517439-A was found to be associated with an increased risk of developing MM.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Oncology

Autophagy in Hematological Malignancies

Olga Garcia Ruiz, Jose Manuel Sanchez-Maldonado, Miguel Angel Lopez-Nevot, Paloma Garcia, Angelica Macauda, Francisca Hernandez-Mohedo, Pedro Antonio Gonzalez-Sierra, Manuel Martinez-Bueno, Eva Perez, Fernando Jesus Reyes-Zurita, Daniele Campa, Federico Canzian, Manuel Jurado, Juan Jose Rodriguez-Sevilla, Juan Sainz

Summary: Autophagy plays a dual role in cancer, both promoting cancer cell survival and preventing tumor growth and progression. It is important in hematological malignancies and may serve as a potential therapeutic target. Genetic variants within autophagy-related genes may modulate the risk of developing hemopathies and patient survival.

CANCERS (2022)

Article Hematology

Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy

Juan Jose Rodriguez-Sevilla, Concepcion Fernandez-Rodriguez, Leyre Bento, Ramon Diez-Feijoo, Sergio Pinzon, Joan Gibert, Lierni Fernandez-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sanchez-Gonzalez, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. Garcia, Lluis Colomo, Beatriz Bellosillo, Antonio Gutierrez, Antonio Salar

Summary: Four clinical or clinicogenetic-risk models were explored in patients with symptomatic FL who received frontline immunochemotherapy. The FLIPI remains the clinical risk score with higher discrimination in patients with advanced FL treated with immunochemotherapy, but the performance of the m7-FLIPI should be further investigated in patients treated with R-B.

BLOOD ADVANCES (2023)

Article Biochemistry & Molecular Biology

GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis

Jose Manuel Sanchez-Maldonado, Antonio Jose Cabrera-Serrano, Subhayan Chattopadhyay, Daniele Campa, Maria del Pilar Garrido, Angelica Macauda, Rob Ter Horst, Andres Jerez, Mihai G. G. Netea, Yang Li, Kari Hemminki, Federico Canzian, Asta Foersti, Juan Sainz

Summary: This study found that obesity-related genetic variants do not impact the risk of developing MM, based on genomic association studies conducted in German and Spanish populations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available